Williams-Sonoma, Inc. (WSM) Tops Q4 EPS by 5c; Issues Q1, FY12 EPS, Revs Outlook
Tweet
Share
E-mailGet Alerts WSM Hot Sheet
Price: $245.72 +0.23%
Financial Fact:
Cost of goods sold: 787.16M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of goods sold: 787.16M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Williams-Sonoma, Inc. (NYSE: WSM) reported Q4 EPS of $1.17, $0.05 better than the analyst estimate of $1.12. Revenue for the quarter came in at $1.27 billion versus the consensus estimate of $1.25 billion.
Williams-Sonoma, Inc. sees Q1 2012 EPS of $0.29-$0.32, versus the consensus of $0.33. Williams-Sonoma, Inc. sees Q1 2012 revenue of $800-$820 million, versus the consensus of $805.21 million.
Williams-Sonoma, Inc. sees FY2012 EPS of $2.37-$2.47, versus the consensus of $2.47. Williams-Sonoma, Inc. sees FY2012 revenue of $3.93-$4.02 million, versus the consensus of $3.91 million.
For earnings history and earnings-related data on Williams-Sonoma, Inc. (WSM) click here.
Williams-Sonoma, Inc. sees Q1 2012 EPS of $0.29-$0.32, versus the consensus of $0.33. Williams-Sonoma, Inc. sees Q1 2012 revenue of $800-$820 million, versus the consensus of $805.21 million.
Williams-Sonoma, Inc. sees FY2012 EPS of $2.37-$2.47, versus the consensus of $2.47. Williams-Sonoma, Inc. sees FY2012 revenue of $3.93-$4.02 million, versus the consensus of $3.91 million.
For earnings history and earnings-related data on Williams-Sonoma, Inc. (WSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- SuperCom (SPCB) Tops Q3 EPS by 43c
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
